Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-03-20

FDA Approved: ZENPEP — Supplemental Application (Aimmune Therapeutics, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ZENPEP (pancrelipase) submitted by Aimmune Therapeutics, updating the labeling related to its use for pancreatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZENPEP (pancrelipase)

Snippet

SUPPL AP for ZENPEP (PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE)